CASSANDRA SHEA GILLIAM

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health MACON, GA NPI 1639652829

General Payments — all program years on this page

$644.80

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 31
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $431.67 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $431.6719

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $213.1312
2024 $431.6719

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1101272331 E.R. Squibb & Sons, L.L.C. $20.63 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137753628 Takeda Pharmaceuticals U.S.A., Inc. $15.84 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137753630 Takeda Pharmaceuticals U.S.A., Inc. $23.31 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137753632 Takeda Pharmaceuticals U.S.A., Inc. $18.01 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137753634 Takeda Pharmaceuticals U.S.A., Inc. $15.32 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143463461 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.90 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143463465 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $124.46 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143463468 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.56 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143463472 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.88 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143463476 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.65 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143463479 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4.28 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143463483 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.69 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143463487 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $12.07 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143463490 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $11.15 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146026434 Lundbeck LLC $25.17 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146026436 Lundbeck LLC $13.68 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146760727 IDORSIA PHARMACEUTICALS US INC $15.72 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146772704 IDORSIA PHARMACEUTICALS US INC $17.66 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147891718 Supernus Pharmaceuticals, Inc. $14.69 03/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.